ecancermedicalscience

Special Issue

Breast cancer brain metastases: new directions in systemic therapy

18 Apr 2013
Nancy U Lin

The management of patients with brain metastases from breast cancer continues to be a major clinical challenge. The standard initial therapeutic approach depends upon the size, location, and number of metastatic lesions and includes consideration of surgical resection, whole-brain radiotherapy, and stereotactic radiosurgery. As systemic therapies for control of extracranial disease improve, patients are surviving long enough to experience subsequent progression events in the brain. Therefore, there is an increasing need to identify both more effective initial treatments as well as to develop multiple lines of salvage treatments for patients with breast cancer brain metastases. This review summarises the clinical experience to date with respect to cytotoxic and targeted systemic therapies for the treatment of brain metastases, highlights ongoing and planned trials of novel approaches and identifies potential targets for future investigation.

Related Articles

Marianne Gnanamuttupulle, Oliver Henke, Shilanaiman Hilary Ntundu, Furaha Serventi, Leila E Mwakipunda, Patrick Amsi, Alex Mremi, Kondo Chilonga, David Msuya, Samuel G Chugulu
Abhishek Sharma, Shagun Mahajan, Sanjit Kumar Agrawal, Rosina Ahmed, Debdeep Dey
Yazmín A Ramírez-Galván, Servando Cardona-Huerta, Guillermo Elizondo-Riojas, Alberto Montemayor-Martínez, Jesús I Morales-Escajeda, Carlos E Herrera-Peña
Aragaw Tesfaw, Hanna Berihun, Eshetie Molla, Gashaw Mihret, Dejen Getaneh Feleke, Ermias Sisay Chanie, Biruk Demissie, Tewodros Yosef, Abel Shita, Fitalew Tadele, Efrem Fenta
Isália Miguel, Fátima Rodrigues, Sofia Fragoso, João Freixo, Ana Clara, Ana Luis, Sandra Bento, Mariana Fernandes, Filipe Bacelar, Sara Câmara, Joana Parreira, Teresa Duarte, Paula Rodrigues, Sidónia Santos, Fátima Vaz